Newer mCRPC Drugs Prolong Survival Better in Blacks Than Whites

The study is the first to show that treatment with abiraterone acetate/enzalutamide is associated with better survival in African American patients with mCRPC compared with Caucasians.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2Ea6KXv